The Ozempic maker is partnering with the AI firm to speed up drug development.
Cryptopolitan on MSN
Novo Nordisk and Anthropic collaborate to advance drug development with Claude
Novo Nordisk is turning to Anthropic’s Claude models in a bid to cut the time needed to develop new medicines and bring them to market. The pharmaceutical giant said Wednesday that the partnership ...
Sept 16 (Reuters) - Novo Nordisk has partnered with Anthropic to use the AI giant's Claude models to speed up discovery and ...
Novo Nordisk and Anthropic announced a collaboration to deploy Claude Science and other frontier AI models to speed up drug ...
Novo Nordisk (NVO) stock rose 4% after announcing an Anthropic AI deal and receiving a European approval recommendation for ...
Novo Nordisk partners with Anthropic to deploy Claude AI and Claude Science across its drug development pipeline, aiming to ...
Novo Nordisk (NVO) partners with Anthropic (ANTHRO) to speed drug discovery and advance AI-driven software development. Read more here..
Novo Nordisk (CPSE:NOVO B) outlined a new 2030 plan targeting several potential blockbuster therapies beyond obesity and ...
Novo Nordisk (NVO) shares are lower as it disappointed investors hoping for concrete turnaround plans from Chief Executive Officer Mike Doustdar after losing its lead in the obesity market to Eli ...
The pharmaceutical company will test Claude Science in research and development workflows and use Anthropic’s models to ...
Novo Nordisk (NVO) stock jumped 4% after unveiling an AI collaboration with Anthropic and securing European approval recommendation for Frehemgo.
Collaboration aims to help Novo discover and develop new medicines faster Novo will use Anthropic models and Claude Science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results